All Stories

  1. Microbiome and metabolome features of the cardiometabolic disease spectrum

    Article • Nature Reports Stem Cells, February 2022, Springer Science + Business Media

    Michael Olanipekun

  2. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Article • Cell, February 2022, Elsevier

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  3. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism

    Article • Gut, January 2022, BMJ

    Michael Olanipekun

  4. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19

    Article • Heart, December 2021, BMJ

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  5. Combinatorial, additive and dose-dependent drug–microbiome associations

    Article • Nature, December 2021, Springer Science + Business Media

    Michael Olanipekun

  6. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

    Article • iScience, November 2021, Elsevier

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  7. Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia

    Article • Scientific Reports, September 2021, Springer Science + Business Media

    Michael Olanipekun

  8. Mapping the human genetic architecture of COVID-19

    Article • Nature, July 2021, Springer Science + Business Media

    Michael Olanipekun, Dr Ahilanandan Dushianthan, Roberta Russo

  9. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

    Article • The Lancet, July 2021, Elsevier

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  10. Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health

    Article • Gut, May 2021, BMJ

    Michael Olanipekun

  11. Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping

    Article • Scientific Reports, September 2018, Springer Science + Business Media

    Michael Olanipekun